NGM Biopharmaceuticals
NGM
$1.54
Share price
0.00%
Change (1 day)
-53.89%
Change (1 year)
Categories
NGM Biopharmaceuticals (NGM) - Total assets
Total assets on the balance sheet as of December 2023 : $0.16 B
According to NGM Biopharmaceuticals's latest financial reports the company's total assets are $0.16 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
NGM Biopharmaceuticals - Total assets on balance sheet (from 2017 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | -45.07% |
| 2022-12-31 | $0.30 B | -23.61% |
| 2021-12-31 | $0.40 B | 22.29% |
| 2020-12-31 | $0.32 B | -13.5% |
| 2019-12-31 | $0.38 B | 54.58% |
| 2018-12-31 | $0.24 B | -1.15% |
| 2017-12-31 | $0.24 B | -10.13% |
| 2016-12-31 | $0.27 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.97 B | 1,068.97% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $18.17 M | -89.24% | 🇺🇸 USA |